Extracting and calibrating evidence of variant pathogenicity from population biobank data.

Abstract excerpt

Genomic medicine requires a robust evidence base of variant phenotypic impacts, which remains incomplete even in extensively studied genes with monogenic disease associations. Here, we evaluated the broad potential of using population cohort data to identify evidence that can be used in variant assessment. Across 41 genes related to 18 clinically actionable monogenic phenotypes, we calculated variant-level odds...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biological Specimen Banks
• Share to Cohort Studies